Comparison of the Effects of the M_1-Receptor Antagonist Telenzepine and the CCK-Receptor Antagonist Loxiglumide on the Pancreatic Secretory Response to Intraduodenal Tryptophan in Dogs
スポンサーリンク
概要
- 論文の詳細を見る
- 1996-11-01
著者
-
Chari S.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim Theodor-k
-
Chari S.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim
-
TEYSSEN S.
Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Theodor
-
NIEBERGALL-ROTH E.
Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Theodor
-
RAUSCH A.
Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Theodor
-
BEGLINGER C.
University Hospital of Basel
-
RIEPL R.
Klinikum Innenstadt, University of Munich
-
SINGER M.
Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Theodor
-
Niebergall-roth E.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim Theodor-k
-
Riepl R.
Klinikum Innenstadt University Of Munich
-
Teyssen S.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim Theodor-k
-
Teyssen S.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim
-
Rausch A.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim Theodor-k
-
Singer M.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim Theodor-k
-
Singer M.
Department Of Medicine Iv (gastroenterology) University Hospital Of Heidelberg At Mannheim
関連論文
- Comparison of the Effects of the M_1-Receptor Antagonist Telenzepine and the CCK-Receptor Antagonist Loxiglumide on the Pancreatic Secretory Response to Intraduodenal Tryptophan in Dogs
- Comparison of Two Dose-Response Techniques to Study the Pancreatic Secretory Response to Intraduodenal Tryptophan in the Absence and Presence of the M_1-Receptor Antagonist Telenzepine